The effects of LXR agonist GW3965 on vascular reactivity and inflammation in hypertensive rat aorta
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 213, 287-293
Abstract
No abstract availableKeywords
Funding Information
- TÜBİTAK (114S170)
- Ankara University (16B0230004)
This publication has 41 references indexed in Scilit:
- Vascular fibrosis in atherosclerosisCardiovascular Pathology, 2013
- Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin IIInternational Journal of Hypertension, 2011
- Liver X Receptor Signaling Pathways and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Targeting the redox regulation of SERCA in vascular physiology and diseaseCurrent Opinion in Pharmacology, 2010
- Effect of antioxidants pQ510 and resveratrol on regulatory function of the endothelium in rats with modeled arterial hypertensionBulletin of Experimental Biology and Medicine, 2007
- GW3965, a synthetic liver X receptor (LXR) agonist, reduces angiotensin II‐mediated pressor responses in Sprague–Dawley ratsBritish Journal of Pharmacology, 2007
- The Inflammatory Aspect of the Microcirculation in Hypertension: Oxidative Stress, Leukocytes/Endothelial Interaction, ApoptosisMicrocirculation, 2002
- Expression of Ca 2+ Transport Genes in Platelets and Endothelial Cells in HypertensionHypertension, 2001
- Enhanced release of endothelium-derived relaxing factor in mineralocorticoid hypertension.Hypertension, 1992
- Alpha-adrenergic receptors and 45Ca2+ efflux in arteries from deoxycorticosterone acetate hypertensive rats.Hypertension, 1992